Pioneering molecular diagnostics company MI:RNA, which uses biomarkers and advanced modelling to diagnose veterinary disease earlier, has reached a growth milestone with the completion of an oversubscribed funding round.
The conclusion of this second Venture Capital (VC) led financing, which has raised $3.6 million, accelerates a rapid period of expansion and commercial progress for the company, as it advances its mission to bring faster, more accurate, and more accessible diagnostic solutions to veterinarians, producers, and animal health professionals worldwide.
Funds have been raised from existing investors including NovaQuest, Scottish Enterprise, Kyoritsu Holdings Corporation, VANE (Angel Syndicate), Animal Health Angels, Equity Gap and Gabriel, as well as new investors Holstein UK and AniVC.
Read more HERE.
